Speaker: Zev Wainberg

Gastroesophageal Cancers | Zev Wainberg, MD, MSc

Research To Practice

Zev Wainberg, MD, regarding the results of the ROAR basket trial from GI 2019

Zev Wainberg, MD, considers the influence of ctDNA testing in the treatment of gastric cancer

What are screening guidelines for GERD and what is risk of developing esophageal cancer?

Dr. Wainberg discusses Advances in Chemotherapy for Pancreatic Cancer

HirshbergFoundation

DKN-01 with bevacizumab and chemotherapy in advanced CRC

NALIRIFOX as frontline therapy for PDAC

NAPOLI-3: first-line NALIRIFOX in metastatic pancreatic ductal adenocarcinoma

What are the most essential biomarkers for patients with gastro-esophageal cancer?

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma

First-line durvalumab + monalizumab in microsatellite-stable CRC

How important is it in gastric cancer to have 15 lymph nodes removed?

What is Barrett's esophagus and what are recommendations for screnning and monitoring?

Oncology Today with Dr Neil Love: Special Edition — Current Management of Gastroesophageal Cancers

Research To Practice

MT-5111: immunotoxin in HER2+ solid tumours

Who might benefit from gastroesophageal cancer screening with risk factors such as Barrett's?

What are the subtypes of esophagogastric cancer and why is it important to distinguish between them?

FIGHT: bemarituzumab + mFOLFOX6 in first-line advanced gastric cancer

What are the risk factors for esophagogastric cancers and why is the incidence rising?

Next steps in gastric cancer